Semler Scientific (NASDAQ:SMLR) Stock Price Up 6.6% – Time to Buy?

Semler Scientific, Inc. (NASDAQ:SMLR) rose 6.6% during trading on Wednesday . The company traded as high as $64.28 and last traded at $63.79. Approximately 199,612 shares traded hands during mid-day trading, a decline of 27% from the average daily volume of 273,106 shares. The stock had previously closed at $59.83.

Semler Scientific Stock Up 7.9 %

The stock’s 50-day simple moving average is $41.21 and its 200 day simple moving average is $33.97. The company has a market cap of $534.89 million, a price-to-earnings ratio of 29.19 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. The company had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Institutional Trading of Semler Scientific

Several hedge funds have recently made changes to their positions in SMLR. CWM LLC lifted its position in shares of Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares in the last quarter. Financial Strategies Group Inc. acquired a new stake in Semler Scientific in the second quarter valued at approximately $263,000. Bank of New York Mellon Corp raised its holdings in Semler Scientific by 10.4% in the second quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company’s stock valued at $709,000 after acquiring an additional 1,940 shares in the last quarter. Rhumbline Advisers raised its holdings in Semler Scientific by 27.1% in the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock valued at $213,000 after acquiring an additional 1,320 shares in the last quarter. Finally, Quest Partners LLC acquired a new stake in Semler Scientific in the second quarter valued at approximately $59,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.